Of note this study also identified that the most consistent and significant increases in IL-36R expression occur in epithelial-originating cancers, including lung squamous cell carcinoma, colon, oesophageal and stomach adenocarcinomas, indicating a possible correlation between IL-36R expression and patient outcomes in these cancers. Here, IL1RL2 is linked to gastric adenocarcinoma.